Home › Entities › clinical_trial › Olaparib With Ceralasertib in Recurrent Osteosarcoma

Olaparib With Ceralasertib in Recurrent Osteosarcoma

clinical trial
MedicalStudy clinical_trial Q96143534
Press Enter · cited answer in seconds

Summary

Olaparib With Ceralasertib in Recurrent Osteosarcoma is a clinical trial[1].

Key Facts

  • Olaparib With Ceralasertib in Recurrent Osteosarcoma is in the country of United States[2].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's instance of is recorded as clinical trial[3].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's start time is recorded as +2020-07-31T00:00:00Z[4].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's end time is recorded as +2023-06-01T00:00:00Z[5].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's contributor to the creative work or subject is recorded as AstraZeneca[6].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's main subject is recorded as pediatric osteosarcoma[7].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's main subject is recorded as osteosarcoma[8].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's number of participants is recorded as {'unit': '1', 'amount': '+63'}[9].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's title is recorded as Phase II Trial of Olaparib in Combination With Ceralasertib in Patients With Recurrent Osteosarcoma[10].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}[11].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's ClinicalTrials.gov ID is recorded as NCT04417062[12].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+30'}[13].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's research intervention is recorded as olaparib[14].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's clinical trial phase is recorded as phase II clinical trial[15].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's research subject recruitment status is recorded as not yet recruiting[16].
  • Olaparib With Ceralasertib in Recurrent Osteosarcoma's study type is recorded as interventional study[17].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Olaparib With Ceralasertib in Recurrent Osteosarcoma. Retrieved May 3, 2026, from https://4ort.xyz/entity/olaparib-with-ceralasertib-in-recurrent-osteosarcoma
MLA “Olaparib With Ceralasertib in Recurrent Osteosarcoma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/olaparib-with-ceralasertib-in-recurrent-osteosarcoma.
BibTeX @misc{4ortxyz_olaparib-with-ceralasertib-in-recurrent-osteosarcoma_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Olaparib With Ceralasertib in Recurrent Osteosarcoma}}, year = {2026}, url = {https://4ort.xyz/entity/olaparib-with-ceralasertib-in-recurrent-osteosarcoma}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Olaparib With Ceralasertib in Recurrent Osteosarcoma — https://4ort.xyz/entity/olaparib-with-ceralasertib-in-recurrent-osteosarcoma (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/olaparib-with-ceralasertib-in-recurrent-osteosarcoma · Last refreshed: